Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

PURPOSE: The combination of gemcitabine and docetaxel (GD) is used to effectively treat patients with soft tissue sarcoma (STS). It is widely considered that the conventional doses used are too high for long term use and many patients must discontinue GD treatment due to its toxicity. Therefore, to...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lee, Ha-young, Shin, Sang Joon, Kim, Hyo Song, Hong, Soo Jung, Han, Jung Woo, Lim, Seung Taek, Roh, Jae Kyung, Rha, Sun Young
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Cancer Association 2012
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3322200/
https://ncbi.nlm.nih.gov/pubmed/22500160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2012.44.1.43
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы